Display options
Cite
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2009;52(11):2469doi: 10.1007/s00125-009-1503-8.
(2009). Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 52(11), 2469. https://doi.org/10.1007/s00125-009-1503-8
"Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group." Diabetologia vol. 52,11 (2009): 2469. doi: https://doi.org/10.1007/s00125-009-1503-8
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2009 Nov;52(11):2469. doi: 10.1007/s00125-009-1503-8. PMID: 28512700; PMCID: PMC6828402.
Copy Download .nbib Format: NLM
Share it on

Diabetologia. 2009 Nov;52(11):2469. doi: 10.1007/s00125-009-1503-8.

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Diabetologia

[No authors listed]

PMID: 28512700 PMCID: PMC6828402 DOI: 10.1007/s00125-009-1503-8

[No abstract available.]

Publication Types